Federal contract award
75A50124F61011
THE PURPOSE OF THIS TASK ORDER IS TO PERFORM A SHORT-TERM PHYSICAL AND CHEMICAL COMPATIBILITY (PC) STUDY ON THE ANTIGEN AND MF59 DOSING COMBINATIONS TO SUPPORT OF THE INTENDED HOLD TIME FOR THE BARDA SPONSORED BPI-23-001 STUDY.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 325414 — Biological Product (except Diagnostic) Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | 75A50122D00004 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $23.7K |
| Current contract value | $23.7K |
| Potential contract value / ceiling | $23.7K |
| Start date | Sep 30, 2024 |
| Current end date | Mar 14, 2025 |
| Potential end date | Mar 14, 2025 |
| Latest award activity | Mar 25, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Mar 25, 2026 | P00002 | $0 | THE PURPOSE OF THIS TASK ORDER IS TO PERFORM A SHORT-TERM PHYSICAL AND CHEMICAL COMPATIBILITY (PC) STUDY ON THE ANTIGEN AND MF59 DOSING COMBINATIONS TO SUPPORT OF THE INTENDED HOLD TIME FOR THE BARDA SPONSORED BPI-23-001 STUDY. |
| Nov 22, 2024 | P00001 | $0 | THE PURPOSE OF THIS NO COST BILATERAL MODIFICATION IS TO EXTEND THE PERIOD OF PERFORMANCE FROM DECEMBER 3, 2024 TO MARCH 14, 2025. |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.